Why carry out this study?

As patient preferences for anaemia treatment attributes remain uncertain, we aimed to better understand how patients with CKD value the attributes associated with anaemia treatments, including the relative importance of these attributes.

What was learned from the study?

Patients with CKD and anaemia consider the mode and frequency of administration to be an important aspect of their treatment, with a preference for oral administration over subcutaneous administration.

Patients with CKD and anaemia are willing to tolerate some increases in the risk of adverse events such as major cardiovascular events and gastrointestinal side effects to switch to a more convenient mode of treatment administration.

Energy levels are deemed to be an important aspect of patient treatment outcomes, with patients willing to tolerate some increase in side effects in exchange for more energy.